Showing 1 - 8 results of 8 for search 'Vladimir Atanasov', query time: 0.03s Refine Results
  1. 1
    Synthesis and Characterization of Novel Perfluoro Aromatic Side Chain Sulfonated PSU Ionomers

    Synthesis and Characterization of Novel Perfluoro Aromatic Side Chain Sulfonated PSU Ionomers by Philipp Martschin, Vladimir Atanasov, Simon Thiele, Jochen Kerres

    Published 2024-10-01
    Get full text
    Article
  2. 2
    Novel Pyrrolidinium-Functionalized Styrene-b-ethylene-b-butylene-b-styrene Copolymer Based Anion Exchange Membrane with Flexible Spacers for Water Electrolysis

    Novel Pyrrolidinium-Functionalized Styrene-b-ethylene-b-butylene-b-styrene Copolymer Based Anion Exchange Membrane with Flexible Spacers for Water Electrolysis by Ziqi Xu, Sofia Delgado, Vladimir Atanasov, Tobias Morawietz, Aldo Saul Gago, Kaspar Andreas Friedrich

    Published 2023-03-01
    Get full text
    Article
  3. 3
    The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin

    The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin by Lorenzo Franchi, Vladimir Atanasov, Mark Stake, Garrett Bates, Kristen Osinski, John R Meurer, Bernard Black

    Published 2024-11-01
    Get full text
    Article
  4. 4
    Publisher Correction: The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin

    Publisher Correction: The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsi... by Lorenzo Franchi, Vladimir Atanasov, Mark Stake, Garrett Bates, Kristen Osinski, John R. Meurer, Bernard Black

    Published 2025-01-01
    Get full text
    Article
  5. 5
    Community focus groups about a COVID-19 individual risk assessment tool: access, understanding and usefulness

    Community focus groups about a COVID-19 individual risk assessment tool: access, understanding and usefulness by Aliyah Keval, Mohammad Titi, Hadi Omar Saleh, Staci Young, Julia Dickson Gomez, Vladimir Atanasov, Bernard Black, John Meurer

    Published 2023-09-01
    Get full text
    Article
  6. 6
    Evidence on COVID-19 Mortality and Disparities Using a Novel Measure, COVID excess mortality percentage: Evidence from Indiana, Wisconsin, and Illinois.

    Evidence on COVID-19 Mortality and Disparities Using a Novel Measure, COVID excess mortality percentage: Evidence from Indiana, Wisconsin, and Illinois. by Vladimir Atanasov, Natalia Barreto, Lorenzo Franchi, Jeff Whittle, John Meurer, Benjamin W Weston, Qian Eric Luo, Andy Ye Yuan, Ruohao Zhang, Bernard Black

    Published 2024-01-01
    Get full text
    Article
  7. 7
    Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records

    Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records by Vladimir Atanasov, Natalia Barreto, Jeff Whittle, John Meurer, Benjamin W. Weston, Qian (Eric) Luo, Andy Ye Yuan, Lorenzo Franchi, Ruohao Zhang, Bernard Black

    Published 2023-05-01
    Get full text
    Article
  8. 8
    Understanding COVID-19 Vaccine Effectiveness against Death Using a Novel Measure: COVID Excess Mortality Percentage

    Understanding COVID-19 Vaccine Effectiveness against Death Using a Novel Measure: COVID Excess Mortality Percentage by Vladimir Atanasov, Natalia Barreto, Jeff Whittle, John Meurer, Benjamin W. Weston, Qian (Eric) Luo, Lorenzo Franchi, Andy Ye Yuan, Ruohao Zhang, Bernard Black

    Published 2023-02-01
    Get full text
    Article

Search Tools: